These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2583945)

  • 1. Attenuation of reserpine-induced catalepsy by melatonin and the role of the opioid system.
    Sandyk R; Mukherjee S
    Int J Neurosci; 1989 Oct; 48(3-4):297-301. PubMed ID: 2583945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin potentiates the effects of naloxone on reserpine-induced catalepsy in the rat.
    Sandyk R; Fisher H
    Int J Neurosci; 1989 Sep; 48(1-2):125-7. PubMed ID: 2583927
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism of dermorphin-induced catalepsy with naloxone, TRH-analog CG3703 and the benzodiazepine antagonist, Ro 15-1788.
    Paakkari P; Feuerstein G
    Neuropharmacology; 1988 Oct; 27(10):1007-12. PubMed ID: 2907115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonists.
    Hubbard CA; Trugman JM
    Mov Disord; 1993 Oct; 8(4):473-8. PubMed ID: 7901761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central action of narcotic analgesics. V. Participation of serotonin in the mechanism of action of narcotic analgesics.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1979; 31(5):461-71. PubMed ID: 44745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive shock (ECS) and H-endorphin-induced analgesia: unconventional interactions with naloxone.
    Urca G; Harouni A; Sarne Y
    Eur J Pharmacol; 1982 Jul; 81(2):237-43. PubMed ID: 6889535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
    Shiozaki S; Ichikawa S; Nakamura J; Kitamura S; Yamada K; Kuwana Y
    Psychopharmacology (Berl); 1999 Nov; 147(1):90-5. PubMed ID: 10591873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic opioids compared with morphine and ketamine: catalepsy, cross-tolerance and interactions in the rat.
    Benthuysen JL; Hance AJ; Quam DD; Winters WD
    Neuropharmacology; 1989 Oct; 28(10):1011-5. PubMed ID: 2530467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of narcotic antagonists on L-dopa reversal of reserpine-induced catalepsy and blepharoptosis in mice.
    Namba MM; Quock RM; Malone MH
    Life Sci; 1981 Apr; 28(14):1629-36. PubMed ID: 7195448
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of GABA-linoleamide and glycine-linoleamide on catalepsy in the rat after chronic administration of reserpine].
    Vamvakidès A
    Agressologie; 1986 Nov; 27(10):835-7. PubMed ID: 3028195
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of melatonin and methionine-enkephalin on surfacing responses in goldfish.
    Satake N
    Physiol Behav; 1979 Dec; 23(6):995-9. PubMed ID: 232274
    [No Abstract]   [Full Text] [Related]  

  • 13. Seasonal and sex influences on ketamine-induced analgesia and catalepsy in the rat; a possible role for melatonin.
    Winters WD; Hance AJ; Cadd GC; Lakin ML
    Neuropharmacology; 1986 Oct; 25(10):1095-101. PubMed ID: 3785578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.
    Singh A; Naidu PS; Kulkarni SK
    Indian J Exp Biol; 2003 Nov; 41(11):1264-8. PubMed ID: 15332494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man.
    Esposti D; Lissoni P; Mauri R; Rovelli F; Orsenigo L; Pescia S; Vegetti G; Esposti G; Fraschini F
    J Endocrinol Invest; 1988 Feb; 11(2):103-6. PubMed ID: 3361078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition.
    Singh A; Naidu PS; Kulkarni SK
    Pharmacology; 2003 Jun; 68(2):81-8. PubMed ID: 12711835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prejunctional modulation of sensory-motor nerve-mediated vasodilatation of the rat mesenteric arterial bed by opioid peptides.
    Ralevic V; Rubino A; Burnstock G
    J Pharmacol Exp Ther; 1994 Feb; 268(2):772-8. PubMed ID: 8113989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives.
    Brown DR; Robertson MJ; Goldberg LI
    Neuropharmacology; 1983 Mar; 22(3):317-21. PubMed ID: 6682490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic profile of n-palmitoylglycine. Its effect on reserpine and haloperidol catalepsy].
    Vamvakidès A
    Boll Chim Farm; 1995 May; 134(5):258-62. PubMed ID: 7546535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoate.
    Egan MF; Ferguson JN; Hyde TM
    Brain Res Bull; 1995; 38(4):355-63. PubMed ID: 8535858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.